EP 4161522 A4 20240626 - PYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS
Title (en)
PYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS
Title (de)
PYRAZOLO[4,3-D PYRIMIDINDERIVATE UND VERFAHREN ZU IHRER VERWENDUNG ZUR BEHANDLUNG VON ZELLPROLIFERATIVEN ERKRANKUNGEN
Title (fr)
DÉRIVÉS DE PYRAZOLO [4,3-D]PYRIMIDINE ET LEURS PROCÉDÉS D'UTILISATION POUR LE TRAITEMENT DE TROUBLES PROLIFÉRATIFS CELLULAIRES
Publication
Application
Priority
- US 202063034687 P 20200604
- US 2021035622 W 20210603
Abstract (en)
[origin: WO2021247809A1] The present invention relates to novel Pyrazolo[4,3-d]Pyrimidine Derivatives of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined herein. The present invention also relates to compositions comprising at least one Pyrazolo[4,3-d]Pyrimidine Derivative, and methods of using the Pyrazolo[4,3-d]Pyrimidine Derivatives for treating or preventing a cellular proliferative disorder in a patient.
IPC 8 full level
A61K 31/519 (2006.01); C07D 231/00 (2006.01); C07D 487/04 (2006.01)
CPC (source: EP US)
A61K 31/519 (2013.01 - US); A61K 39/3955 (2013.01 - US); C07D 487/04 (2013.01 - EP US); C07D 519/00 (2013.01 - EP US)
Citation (search report)
- [X] WO 2020028610 A1 20200206 - BRISTOL MYERS SQUIBB CO [US]
- [X] WO 2020028608 A1 20200206 - BRISTOL MYERS SQUIBB CO [US]
- [X] WO 2015193168 A1 20151223 - UCB BIOPHARMA SPRL [BE], et al
- See also references of WO 2021247809A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021247809 A1 20211209; EP 4161522 A1 20230412; EP 4161522 A4 20240626; US 2023219962 A1 20230713
DOCDB simple family (application)
US 2021035622 W 20210603; EP 21817382 A 20210603; US 202117927222 A 20210603